Triethylamine → HCID 23533346, 화합물
반응식
CN1CCN(C2C=C[C:11]3[C:12](C=2)=[CH:13][CH:14]=[C:15]2[C:20]=3[O:19][C:18]([C:21]([NH:23][C:24]3[CH:29]=[CH:28][C:27]([N:30]4[CH2:35][CH2:34][O:33][CH2:32][CH2:31]4)=[CH:26][CH:25]=3)=[O:22])=[CH:17][C:16]2=[O:36])CC1.C1C=CC2N(O)N=NC=2C=1.CN([C:51]([O:55]N1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[CH2:70]([N:72]([CH2:75]C)[CH2:73][CH3:74])[CH3:71].COC1C=C([N:85]2CCOCC2)C=CC=1N>CN(C)C1C=CN=CC=1.CN(C)C=O.C(OCC)(=O)C>[CH3:51][O:55][C:29]1[CH:28]=[C:27]([N:30]2[CH2:31][CH2:32][O:33][CH2:34][CH2:35]2)[CH:26]=[CH:25][C:24]=1[NH:23][C:21]([C:18]1[O:19][C:20]2[C:15]([C:16](=[O:36])[CH:17]=1)=[CH:14][CH:13]=[CH:12][C:11]=2[N:85]1[CH2:74][CH2:73][N:72]([CH3:75])[CH2:70][CH2:71]1)=[O:22]참가 물질
9
반응물 5
생성물 1
시약·촉매·용매 3
실험 절차
8-(4-Methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid hydrochloride (Reference Example 1) (9.10 g, 0.35 mmol), HOBt (0.10 g, 0.7 mmol), TBTU (0.225 g, 0.7 mmol), 4-(dimethylamino)pyridine (0.01 g, catalytic amount), triethylamine (0.15 mL, 1.04 mmol), and commercially available 2-methoxy-4-morpholin-4-yl-phenylamine (SALOR) (0.08 g, 0.38 mmol) were dissolved in dimethylformamide (2.5 mL) and stirred at room temperature overnight. Ethyl acetate (150 mL) was added and the resulting mixture was washed with water (3×50 mL), dried (Na2SO4), filtered, concentrated under vacuum and triturated with ether to yield a yellow solid (85 mg, 54%). LCMS: m/z=480.3.
후처리
- washthe resulting mixture was washed with water (3×50 mL)
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated under vacuum
- customtriturated with ether
출처 및 근거
- ORD 기록
- ord-a33e34d9be1d4ffe8663b4afbcfc7026
- 출처 데이터셋
- uspto-grants-2004_11
- 특허 번호
- US06812225B2
반응 노트
불러오는 중…